|
UK Industry Groups Update Guidance on Insurance for Phase I Trials
UK sponsors of Phase I clinical trials should take out adequate insurance policies in order to accelerate ethics committee review processes and assure volunteers they will be compensated for an injury or adverse event suffered as a result of the study, according to a new industry best practice guideline.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives